Ovarian Low Malignant Potential Tumor - 24 Studies Found
Completed |
: Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors :
|
Completed |
: Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor :
|
Active, not recruiting |
: Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer :
|
Completed |
: 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) :
|
Completed |
: Collecting Tumor Samples From Patients With Gynecological Tumors :
: |
Completed |
: Gefitinib in Treating Patients With Cervical Cancer :
: 2002-11-12 : |
Completed |
: Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer : Cancer : 2002-09-06 : Drug: vorinostat |
Completed |
: Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer :
|
Completed |
: Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer :
: 2006-09-29 :
|